Aortic Stenosis Risk and Life's Crucial 9: The Role of Proteomics and Inflammation
- PMID: 40757799
- DOI: 10.1093/eurjpc/zwaf491
Aortic Stenosis Risk and Life's Crucial 9: The Role of Proteomics and Inflammation
Abstract
Aim: To investigate the association between Life's Crucial 9 (LC9) and the risk of aortic stenosis, and the mediating roles of plasma proteomics and inflammatory biomarkers.
Methods: This study analyzed 295,828 UK Biobank participants (including 31,522 with available proteomics data) without aortic stenosis at baseline. LC9 score was categorized into three groups: low (0-49 points), moderate (50-79 points), and high (80-100 points).
Results: Compared with participants in the low LC9 group, those in the moderate (HR: 0.49, 95% CI: 0.44-0.55) and high groups (HR: 0.28, 95% CI: 0.23-0.34) had a significantly lower aortic stenosis risk. The population attributable risk for aortic stenosis risk associated with low/moderate LC9 was 43.6% (95%CI: 34.1-53.0%). A proteomic signature for LC9, consisting of 549 proteins, was constructed and found to be primarily involved in pathways related to lipid metabolism, immune function and inflammation. The proteomic signature significantly mediated 35.9% of the association between LC9 and aortic stenosis risk, with ADM showing the highest mediating proportion at 20.9%, followed by FABP4 (18.6%), HGF (17.3%), HAVCR1 (17.0%) and GDF15 (15.8%). Inflammatory biomarkers also mediated a small but significant proportion of LC9-related aortic stenosis risk, with mediating proportions ranging from 1.0 to 5.9%.
Conclusions: Higher LC9 score was associated with reduced aortic stenosis risk. This inverse relationship was significantly mediated by plasma proteomics and inflammatory biomarkers. These findings underscore the importance of adherence to LC9 guidelines for the prevention of aortic stenosis, and provide insights into the biological pathways linking cardiovascular health to aortic stenosis.
Keywords: Aortic stenosis; Inflammatory biomarke; Life’s Crucial 9; Proteomics.
Plain language summary
Using data from the UK Biobank, this study examined the relationship between Life's Crucial 9 (LC9) score and the risk of aortic stenosis, and the mediating roles of plasma proteomics and inflammatory biomarkers. A higher LC9 score was associated with a reduced risk of aortic stenosis. This inverse association was partly mediated by plasma proteomics and inflammatory biomarkers.These findings underscore the importance of adherence to LC9 guidelines for improving cardiovascular health as a potential strategy in the prevention of aortic stenosis, and provide evidence for the underlying pathways that link cardiovascular health to aortic stenosis.
© The Author(s) 2025. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
Comment in
-
Reimagining Aortic Stenosis as a Modifiable Disease.Eur J Prev Cardiol. 2025 Sep 16:zwaf582. doi: 10.1093/eurjpc/zwaf582. Online ahead of print. Eur J Prev Cardiol. 2025. PMID: 40972555 No abstract available.
LinkOut - more resources
Full Text Sources
Research Materials
